All changes for the tissue central nervous system (737)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA174
protein inhibitor of activated STAT, 3
Molecular
brain
Human
PIAS3
10.0% Increase Gene Expression Level
DAA186
protein kinase C, beta
Molecular
brain
Human
PRKCB
11.0% Decrease Gene Expression Level
DAA187
protein kinase C, gamma
Molecular
brain
Human
PRKCG
12.0% Decrease Gene Expression Level
DAA188
protein kinase C, zeta
Molecular
brain
Human
PRKCZ
12.0% Decrease Gene Expression Level
DAA167
protein-L-isoaspartate (D-aspartate) O-methyltransferase
Molecular
brain
Human
PCMT1
12.0% Decrease Gene Expression Level
DAA182
protein phosphatase 1E (PP2C domain containing)
Molecular
brain
Human
PPM1E
17.0% Decrease Gene Expression Level
DAA183
protein phosphatase 2 (formerly 2A), regulatory subunit A, alpha isoform
Molecular
brain
Human
PPP2R1A
6.0% Decrease Gene Expression Level
DAA184
protein phosphatase 5, catalytic subunit
Molecular
brain
Human
PPP5C
7.0% Decrease Gene Expression Level
DAA190
protein tyrosine phosphatase, receptor type, E
Molecular
brain
Human
PTPRE
39.0% Decrease Gene Expression Level
DAA1424
protein tyrosine phosphatase, receptor type, O
Molecular
hippocampus
Mouse
Ptpro
5.0% Decrease Gene Expression Level
DAA1269
protocadherin beta 9
Molecular
brain
Mouse
Pcdhb9
7.0% Increase Gene Expression Level
DAA1271
PRP38 pre-mRNA processing factor 38 (yeast) domain containing A
Molecular
brain
Mouse
Prpf38a
2.0% Increase Gene Expression Level
DAA1421
pyruvate dehydrogenase kinase, isoenzyme 4
Molecular
hippocampus
Mouse
Pdk4
6.0% Increase Gene Expression Level
DAA192
quaking homolog, KH domain RNA binding (mouse)
Molecular
brain
Human
QKI
8.0% Increase Gene Expression Level
DAA193
RAB2A, member RAS oncogene family
Molecular
brain
Human
RAB2A
11.0% Decrease Gene Expression Level
DAA194
RAB3A, member RAS oncogene family
Molecular
brain
Human
RAB3A
11.0% Decrease Gene Expression Level
DAA203
radixin
Molecular
brain
Human
RDX
13.0% Increase Gene Expression Level
DAA197
RAP2A, member of RAS oncogene family
Molecular
brain
Human
RAP2A
28.0% Decrease Gene Expression Level
DAA1428
Ras and Rab interactor 2
Molecular
hippocampus
Mouse
Rin2
7.0% Increase Gene Expression Level
DAA200
Ras association (RalGDS/AF-6) domain family member 2
Molecular
brain
Human
RASSF2
18.0% Increase Gene Expression Level
DAA1427
ras homolog gene family, member B
Molecular
hippocampus
Mouse
Rhob
2.0% Increase Gene Expression Level
DAA199
Ras protein-specific guanine nucleotide-releasing factor 1
Molecular
brain
Human
RASGRF1
22.0% Decrease Gene Expression Level
DAA1980
Reaction time for a visually paced simple motor task increases with age
Physiological
brain
Human
—
—
DAA769
Reaction time slowing in tasks with conflict between visual stimulus and required motor response
Psychological
brain
Human
—
—
DAA960
Receptor expression alterations
Physiological
grey matter
Human
—
—
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA174 | protein inhibitor of activated STAT, 3 | Molecular | brain | Human | PIAS3 | 10.0% Increase Gene Expression Level | |
DAA186 | protein kinase C, beta | Molecular | brain | Human | PRKCB | 11.0% Decrease Gene Expression Level | |
DAA187 | protein kinase C, gamma | Molecular | brain | Human | PRKCG | 12.0% Decrease Gene Expression Level | |
DAA188 | protein kinase C, zeta | Molecular | brain | Human | PRKCZ | 12.0% Decrease Gene Expression Level | |
DAA167 | protein-L-isoaspartate (D-aspartate) O-methyltransferase | Molecular | brain | Human | PCMT1 | 12.0% Decrease Gene Expression Level | |
DAA182 | protein phosphatase 1E (PP2C domain containing) | Molecular | brain | Human | PPM1E | 17.0% Decrease Gene Expression Level | |
DAA183 | protein phosphatase 2 (formerly 2A), regulatory subunit A, alpha isoform | Molecular | brain | Human | PPP2R1A | 6.0% Decrease Gene Expression Level | |
DAA184 | protein phosphatase 5, catalytic subunit | Molecular | brain | Human | PPP5C | 7.0% Decrease Gene Expression Level | |
DAA190 | protein tyrosine phosphatase, receptor type, E | Molecular | brain | Human | PTPRE | 39.0% Decrease Gene Expression Level | |
DAA1424 | protein tyrosine phosphatase, receptor type, O | Molecular | hippocampus | Mouse | Ptpro | 5.0% Decrease Gene Expression Level | |
DAA1269 | protocadherin beta 9 | Molecular | brain | Mouse | Pcdhb9 | 7.0% Increase Gene Expression Level | |
DAA1271 | PRP38 pre-mRNA processing factor 38 (yeast) domain containing A | Molecular | brain | Mouse | Prpf38a | 2.0% Increase Gene Expression Level | |
DAA1421 | pyruvate dehydrogenase kinase, isoenzyme 4 | Molecular | hippocampus | Mouse | Pdk4 | 6.0% Increase Gene Expression Level | |
DAA192 | quaking homolog, KH domain RNA binding (mouse) | Molecular | brain | Human | QKI | 8.0% Increase Gene Expression Level | |
DAA193 | RAB2A, member RAS oncogene family | Molecular | brain | Human | RAB2A | 11.0% Decrease Gene Expression Level | |
DAA194 | RAB3A, member RAS oncogene family | Molecular | brain | Human | RAB3A | 11.0% Decrease Gene Expression Level | |
DAA203 | radixin | Molecular | brain | Human | RDX | 13.0% Increase Gene Expression Level | |
DAA197 | RAP2A, member of RAS oncogene family | Molecular | brain | Human | RAP2A | 28.0% Decrease Gene Expression Level | |
DAA1428 | Ras and Rab interactor 2 | Molecular | hippocampus | Mouse | Rin2 | 7.0% Increase Gene Expression Level | |
DAA200 | Ras association (RalGDS/AF-6) domain family member 2 | Molecular | brain | Human | RASSF2 | 18.0% Increase Gene Expression Level | |
DAA1427 | ras homolog gene family, member B | Molecular | hippocampus | Mouse | Rhob | 2.0% Increase Gene Expression Level | |
DAA199 | Ras protein-specific guanine nucleotide-releasing factor 1 | Molecular | brain | Human | RASGRF1 | 22.0% Decrease Gene Expression Level | |
DAA1980 | Reaction time for a visually paced simple motor task increases with age | Physiological | brain | Human | — | — | |
DAA769 | Reaction time slowing in tasks with conflict between visual stimulus and required motor response | Psychological | brain | Human | — | — | |
DAA960 | Receptor expression alterations | Physiological | grey matter | Human | — | — |